Assessing the Effect of Augmented Reality on Procedural Outcomes During Ultrasound-Guided Vascular Access.
Michele S Saruwatari, Trong N Nguyen, Hadi Fooladi Talari...
https://pubmed.ncbi.nlm.nih.gov/37573178/Actively Recruiting
Led by University of Alabama at Birmingham · Updated on 2026-03-10
50
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to evaluate the benefits of using augmented reality technology during ultrasound-guided vascular access procedures. It focuses on improving the success rate, efficiency, and ease of placing peripheral venous catheters, peripherally inserted central venous catheters, and central venous catheters. The study is sponsored by the University of Alabama at Birmingham and does not involve blinding. Participants will be randomly assigned to one of two groups one group will receive ultrasound-guided vascular access without augmented reality assistance, while the other group will have the procedure performed with the help of a Microsoft HoloLens 2 augmented reality headset. The study compares the use of this technology to standard care during vascular access. During the study, researchers will measure the success of vascular access by confirming blood return and guide wire advancement within 30 minutes. They will also track the number of needle sticks and the time needed to achieve successful access. Participants will be monitored throughout the procedure to assess these outcomes and the overall impact of augmented reality assistance.
CONDITIONS
Investigating the Utility of Augmented Reality Assistance for Ultrasound-Guided Vascular Access
J
Jeffrey Coote Principal Investigator, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Alabama at Birmingham
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | AR-Assisted Ultrasound-Guided Vascular Access | Standard Ultrasound-Guided Vascular Access |
|---|---|---|
| What is it? | Augmented reality headset (Microsoft HoloLens 2) is used to overlay visual cues during ultrasound-guided vascular access, aiming to support clinicians throughout the procedure. | Standard ultrasound-guided vascular access is performed without any augmented reality device or visual overlay support. |
| Role in the trial | The investigational arm; evaluates if AR assistance impacts success, time, or number of needle sticks needed for vascular access. | The control arm; represents usual ultrasound-guided vascular access practice for comparison against AR assistance. |
| Primary use | To provide real-time visual guidance and overlays during ultrasound-guided vascular access, aiming to improve placement success and efficiency. | To perform ultrasound-guided vascular access without AR, following standard procedural practice. |
| How it is given or performed | Clinician wears the AR headset, which displays guiding information and visual cues while performing the ultrasound-guided procedure. | Clinician performs vascular access using standard ultrasound guidance, without headset or visual overlays. |
| Evidence status | Current evidence is limited; prior studies suggest AR support may help with efficiency and performance in procedural settings, but results are not yet conclusive for clinical outcomes in vascular access. | Considered standard practice for vascular access requiring ultrasound guidance, supported by current guidelines and extensive experience. |
| Important limitations | Evidence for clinical benefit in vascular access is limited to small studies; headset use may introduce workflow changes, require technical training, and may not generalize to all patient or operator types. | Success still varies with operator skill and patient factors; technology advances may eventually change current practice. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 minutes
Participants receive ultrasound-guided vascular access procedures with or without augmented reality assistance as part of the study intervention.
1 procedure visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Michele S Saruwatari, Trong N Nguyen, Hadi Fooladi Talari...
https://pubmed.ncbi.nlm.nih.gov/37573178/University of Alabama at Birmingham
Lead Sponsor